Regulating IL-2 immune signaling function via a core allosteric structural network

Area of Science:

• Immunology
• Biochemistry
• Computational Biology

Background:

• Human interleukin-2 (IL-2) is vital for T cell regulation but has limited efficacy due to toxicity.
• Current therapies focus on receptor binding site modifications, overlooking IL-2's internal dynamics.
• Understanding IL-2's dynamics is key to developing safer, more effective immunotherapies.

Purpose of the Study:

• To characterize the dynamics of wild-type IL-2 and engineered superkines (S1, S15).
• To explore the role of allosteric networks and conformational exchange in IL-2 function.
• To identify novel strategies for designing IL-2-based immunotherapies with improved selectivity.

Main Methods:

• Nuclear Magnetic Resonance (NMR) spectroscopy to analyze IL-2 dynamics.
• Molecular dynamics (MD) simulations to model conformational changes.
• Rational design of mutations to probe allosteric networks.

Main Results:

• Significant differences in core dynamic pathways and exchange rates were observed between wild-type IL-2 and superkines.
• Superkines exhibit distinct allosteric networks and excited-state conformations.
• A L56A mutation in S1 partially restored wild-type dynamics and function.
• IL-2 core dynamics are critical for receptor binding and signaling.

Conclusions:

• IL-2's internal dynamics and allosteric networks significantly influence its function.
• Modulating these dynamics offers a new avenue for engineering IL-2 immunotherapies.
• This approach can lead to improved immune cell selectivity and reduced toxicity.